Related Experiment Video
Updated: Aug 2, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Influence of an abnormal ankle-brachial index on ischemic and bleeding events in patients undergoing percutaneous
Hangyul Kim1, Seung Do Lee1, Hyo Jin Lee1
1Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea.
Insights
An abnormal ankle-brachial index (ABI) increases risks for bleeding and ischemic events after percutaneous coronary intervention (PCI). This finding aids in optimizing secondary prevention strategies for PCI patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Vascular Medicine
Background:
- Bleeding events post-percutaneous coronary intervention (PCI) significantly impact patient prognosis.
- Limited data exists on how abnormal ankle-brachial index (ABI) affects both ischemic and bleeding risks in PCI patients.
Purpose of the Study:
- To investigate the association between an abnormal ankle-brachial index (ABI) and adverse clinical outcomes, including ischemic and bleeding events, in patients undergoing PCI.
Main Methods:
- A cohort of 4,747 patients undergoing PCI with available ABI data (≤ 0.9 or > 1.4) was analyzed.
- The primary endpoint comprised a composite of all-cause death, myocardial infarction (MI), stroke, and major bleeding.
- Outcomes were assessed over a median follow-up of 31 months.
Main Results:
- An abnormal ABI was present in 12.9% of patients (610 individuals).
- The 5-year cumulative incidence of the primary endpoint was significantly higher in the abnormal ABI group (36.0%) compared to the normal ABI group (14.5%).
- Abnormal ABI independently predicted all-cause death (HR, 3.05), stroke (HR, 1.79), and major bleeding (HR, 1.61).
Conclusions:
- An abnormal ankle-brachial index is identified as a significant risk factor for both ischemic and bleeding complications following PCI.
- These findings can inform the development of tailored secondary prevention strategies for patients after PCI.
Background/Aims:
Bleeding events after percutaneous coronary intervention (PCI) have important prognostic implications. Data on the influence of an abnormal ankle-brachial index (ABI) on both ischemic and bleeding events in patients undergoing PCI are limited.
Methods:
We included patients who underwent PCI with available ABI data (abnormal ABI, ≤ 0.9 or > 1.4). The primary endpoint was the composite of all-cause death, myocardial infarction (MI), stroke, and major bleeding.
Results:
Among 4,747 patients, an abnormal ABI was observed in 610 patients (12.9%). During follow-up (median, 31 months), the 5-year cumulative incidence of adverse clinical events was higher in the abnormal ABI group than in the normal ABI group: primary endpoint (36.0% vs. 14.5%, log-rank test, p < 0.001); all-cause death (19.4% vs. 5.1%, log-rank test, p < 0.001); MI (6.3% vs. 4.1%, log-rank test, p = 0.013); stroke (6.2% vs. 2.7%, log-rank test, p = 0.001); and major bleeding (8.9% vs. 3.7%, log-rank test, p < 0.001). An abnormal ABI was an independent risk factor for all-cause death (hazard ratio [HR], 3.05; p < 0.001), stroke (HR, 1.79; p = 0.042), and major bleeding (HR, 1.61; p = 0.034).
Conclusion:
An abnormal ABI is a risk factor for both ischemic and bleeding events after PCI. Our study findings may be helpful in determining the optimal method for secondary prevention after PCI.
More Related Videos
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease V: Postoperative Nursing Management
Sites for measruring blood pressure
The Brachial Artery: Primary Site for Blood Pressure Measurement
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease I: Introduction
Pre-Procedural Guidelines for Assessing Blood Pressure

